The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cancer activation pathways of thymic epithelial tumors (TETs) by targeted gene expression analysis.
 
Jose Carlos Benitez
No Relationships to Disclose
 
Bastien Job
No Relationships to Disclose
 
Vincent Thomas de Montpreville
No Relationships to Disclose
 
Ludovic Lacroix
No Relationships to Disclose
 
Patrick Saulnier
No Relationships to Disclose
 
Riad Arana
No Relationships to Disclose
 
Olivier Lambotte
No Relationships to Disclose
 
Foundation Cancer and Autoimmune/inflammatory diseases Relationships
No Relationships to Disclose
 
Sacha Mussot
No Relationships to Disclose
 
Olaf Mercier
No Relationships to Disclose
 
Elie Fadel
No Relationships to Disclose
 
Jean-Yves Scoazec
No Relationships to Disclose
 
Benjamin Besse
Research Funding - 4D Pharma (Inst); Abbvie (Inst); Amgen (Inst); Aptitude Health (Inst); AstraZeneca (Inst); BeiGene (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Cergentis (Inst); Cristal Therapeutics (Inst); Daiichi Sankyo (Inst); GlaxoSmithKline (Inst); Inivata (Inst); Janssen Oncology (Inst); Lilly (Inst); Onxeo (Inst); OSE Immunotherapeutics (Inst); Pfizer (Inst); Roche/Genentech (Inst); Sanofi (Inst); Takeda (Inst); Tolero Pharmaceuticals (Inst)